
Spatial Omics Market
Spatial OMICS Market Forecasts to 2030 - Global Analysis By Solution Type (Instruments, Consumables and Software), Sample Type, Workflow, Technology, Application, End User and By Geography

According to Stratistics MRC, the Global Spatial OMICS Market is accounted for $416.20 million in 2024 and is expected to reach $830.79 million by 2030 growing at a CAGR of 12.21% during the forecast period. Spatial OMICS is an advanced field of study that integrates spatial information with omics data, such as genomics, transcriptomics, proteomics, and metabolomics, to provide a detailed molecular and spatial understanding of biological systems. Spatial omics maintains the spatial organization of cells and tissues, allowing researchers to view and examine molecular data in its natural biological setting, in contrast to traditional omics techniques that frequently lose spatial context because of bulk analysis.
According to a study published in Nucleic Acids Research, SpatialRef is a manually curated spatial omics database that aggregates over 9 million manually annotated spots across multiple species.
Market Dynamics:
Driver:
Growing interest in customized treatment
One of the strongest factors propelling the spatial OMICS market is the move toward personalized or precision medicine. A thorough grasp of the cellular and molecular dynamics of diseases in particular patient populations is necessary for personalized treatments. Scientists can produce intricate maps of cellular heterogeneity within tissues using spatial OMICS technologies, which provide vital insights into drug responses, therapeutic targets, and disease mechanisms. Additionally, this is especially helpful in neurological disorders, where knowledge of the molecular mechanisms underlying the various brain regions can guide treatment strategies, and oncology, where tumor complexity varies greatly from patient to patient.
Restraint:
High equipment and technology costs
The high cost of the sophisticated tools and technologies needed for the creation and analysis of spatial data is one of the main factors limiting the market for spatial OMICS. High-resolution microscopes, mass spectrometers, and next-generation sequencers are just a few examples of the costly equipment used in spatial transcriptomics, spatial proteomics, and spatial metabolomics. The financial burden is further increased by the price of consumables, reagents, and specialized bioinformatics software. Furthermore, these large upfront costs can be unaffordable for many smaller businesses and research institutions, which restrict their access to and use of spatial OMICS technologies.
Opportunity:
Developments in the integration of multiple omics
Integrating multi-omics data—such as transcriptomics, proteomics, metabolomics, and genomics—with spatial data is one of the most exciting prospects in the spatial OMICS market. Through the integration of spatial context and molecular information, this potent combination enables researchers to obtain a thorough understanding of biological processes. Identification of cellular interactions and microenvironmental factors that impact drug response, disease progression, and other physiological processes is made possible by the ability to visualize the localization of genes, proteins, or metabolites within tissues. Moreover, this multi-omics approach is especially helpful in fields like drug development, neuroscience, and cancer research, where a molecular understanding of spatial heterogeneity can result in advances in targeted therapies and personalized medicine.
Threat:
Complexity of data and analysis difficulties
One other major threat is the complexity of spatial omics data. Due to the vast amount of data produced by spatially resolved molecular profiling and the complex relationships among the various omics data layers, data analysis and interpretation are exceedingly difficult. Additionally, in order to integrate, visualize, and interpret the additional layer of complexity brought about by the spatial dimension, specific software and computational techniques are needed. Even seasoned researchers may find it difficult to draw significant conclusions from these intricate datasets without strong computing infrastructure and advanced bioinformatics knowledge.
Covid-19 Impact:
The market for spatial OMICS was significantly impacted by the COVID-19 pandemic, which sped up the adoption of advanced omics technologies as scientists and medical professionals tried to track the virus's mutations, comprehend its behaviour, and create vaccines and targeted treatments. The demand for spatial omics tools, especially in the domains of transcriptomics, proteomics, and genomics, increased due to the requirement for extensive, high-resolution molecular data to investigate the virus at a spatial level. Investments in spatial omics technologies were fuelled by this spike in interest, which encouraged innovation and increased the range of uses for these technologies in immunology and virology.
The Formalin-Fixed Paraffin-Embedded (FFPE) Tissue segment is expected to be the largest during the forecast period
In the spatial OMICS market, the formalin-fixed paraffin-embedded (FFPE) tissue segment is expected to have the largest share. Retrospective studies frequently use FFPE tissue samples because of their long shelf life and ease of storage in clinical and research settings. These tissue samples allow for a thorough examination of gene expression, protein levels, and other molecular properties in relation to tissue architecture because they maintain the molecular integrity of biological specimens. Moreover, many omics-based methods, including spatial transcriptomics, spatial proteomics, and others, use FFPE samples to investigate diseases like cancer, infectious diseases, and neurodegenerative conditions.
The Data Analysis segment is expected to have the highest CAGR during the forecast period
In the spatial OMICS market, the data analysis segment is anticipated to grow at the highest CAGR. The demand for sophisticated bioinformatics tools and data analysis platforms has increased as a result of the massive volumes of complex, multidimensional data generated by spatial omics technologies. In order to process, integrate, and interpret the spatially resolved molecular data, this section covers the creation and use of advanced machine learning algorithms, artificial intelligence, and statistical models. Additionally, innovation in data analysis techniques is being fueled by the growing complexity of spatial omics data, which blends genomic, transcriptomic, proteomic, and imaging data.
Region with largest share:
The market for spatial OMICS is expected to be largest share by the North America segment. A strong presence of top academic institutions and biotechnology companies, substantial investments in research and development, and an established healthcare infrastructure all contribute to the region's advantages. With a strong need for state-of-the-art instruments in research in oncology, immunology, and neurology, the US has been at the forefront of developments in spatial omics technologies. Innovation and the use of spatial omics in many different fields have been fuelled by the presence of important players and significant funding from the public and private sectors. Furthermore, the regulatory framework in North America also encourages the creation and application of cutting-edge biomedical technologies, which strengthens the region's market leadership.
Region with highest CAGR:
In the spatial OMICS market, the Asia Pacific region is anticipated to have the highest CAGR. Adoption of spatial omics technologies in the region is being driven by the biotechnology sector's explosive growth as well as rising investments in research and healthcare infrastructure. Significant advancements in genomics, molecular biology, and biomedical research are being made by nations like China, Japan, and India, which is increasing the need for spatial omics tools in both academic and clinical settings. Moreover, improvements in data analysis skills and the growing emphasis on infectious diseases, cancer research, and personalized medicine in these fields are also fueling the market's explosive growth.
Key players in the market
Some of the key players in Spatial OMICS market include Biognosys AG, Ultivue, Inc., Diagenode Diagnostics (Hologic, Inc.), Advanced Cell Diagnostics, Inc., Fluidigm Corporation, Danaher Corporation, Bruker Corporation, ZEISS Group, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., NanoString Technologies, Inc., Akoya Biosciences, Inc., Brooks Automation, Inc., Vizgen Corporation and Rebus Biosystems, Inc.
Key Developments:
In April 2024, Bio-Rad Laboratories, Inc. a global leader in life science research and clinical diagnostics products, announced a collaboration agreement with Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, to develop and commercialize transplant monitoring products using Bio-Rad’s Droplet Digital™ PCR (ddPCR™) instruments and reagents.
In February 2024, Life sciences and diagnostics company Bruker has agreed to acquire ELITechGroup, a provider of in-vitro diagnostic (IVD) systems, in a €870m ($942m) cash deal. ELITechGroup will be acquired from TecFin, a controlled affiliate of pre-eminent private equity company PAI Partners.
In January 2024, Biognosys announced the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers.
Solution Types Covered:
• Instruments
• Consumables
• Software
Sample Types Covered:
• Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
• Fresh Frozen Tissue
Workflows Covered:
• Sample Preparation
• Instrumental Analysis
• Data Analysis
Technologies Covered:
• Spatial Transcriptomics
• Spatial Proteomics
• Spatial Genomics
Applications Covered:
• Diagnostics
• Translation Research
• Drug Discovery and Development
• Single Cell Analysis
• Cell Biology
• Other Applications
End Users Covered:
• Academic and Research Institutions
• Biopharmaceutical & Biotechnological Companies
• Contract Research Organization
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Spatial OMICS Market, By Solution Type
5.1 Introduction
5.2 Instruments
5.2.1 Mode
5.2.1.1 Automated
5.2.1.2 Semi-automated
5.2.1.3 Manual
5.2.2 Type
5.2.2.1 Sequencing Platforms
5.2.2.2 IHC
5.2.2.3 Microscopy
5.2.2.4 Flow Cytometry
5.2.2.5 Mass Spectrometry
5.2.2.6 Other Types
5.3 Consumables
5.4 Software
5.4.1 Bioinformatics Tools
5.4.2 Imaging Tools
5.4.3 Storage & Management Databases
6 Global Spatial OMICS Market, By Sample Type
6.1 Introduction
6.2 Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
6.3 Fresh Frozen Tissue
7 Global Spatial OMICS Market, By Workflow
7.1 Introduction
7.2 Sample Preparation
7.3 Instrumental Analysis
7.4 Data Analysis
8 Global Spatial OMICS Market, By Technology
8.1 Introduction
8.2 Spatial Transcriptomics
8.3 Spatial Proteomics
8.4 Spatial Genomics
9 Global Spatial OMICS Market, By Application
9.1 Introduction
9.2 Diagnostics
9.3 Translation Research
9.4 Drug Discovery and Development
9.5 Single Cell Analysis
9.6 Cell Biology
9.7 Other Applications
10 Global Spatial OMICS Market, By End User
10.1 Introduction
10.2 Academic and Research Institutions
10.3 Biopharmaceutical & Biotechnological Companies
10.4 Contract Research Organization
10.5 Other End Users
11 Global Spatial OMICS Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Biognosys AG
13.2 Ultivue, Inc.
13.3 Diagenode Diagnostics (Hologic, Inc.)
13.4 Advanced Cell Diagnostics, Inc.
13.5 Fluidigm Corporation
13.6 Danaher Corporation
13.7 Bruker Corporation
13.8 ZEISS Group
13.9 Bio-Rad Laboratories, Inc.
13.10 PerkinElmer, Inc.
13.11 NanoString Technologies, Inc.
13.12 Akoya Biosciences, Inc.
13.13 Brooks Automation, Inc.
13.14 Vizgen Corporation
13.15 Rebus Biosystems, Inc.
List of Tables
1 Global Spatial OMICS Market Outlook, By Region (2022-2030) ($MN)
2 Global Spatial OMICS Market Outlook, By Solution Type (2022-2030) ($MN)
3 Global Spatial OMICS Market Outlook, By Instruments (2022-2030) ($MN)
4 Global Spatial OMICS Market Outlook, By Mode (2022-2030) ($MN)
5 Global Spatial OMICS Market Outlook, By Type (2022-2030) ($MN)
6 Global Spatial OMICS Market Outlook, By Consumables (2022-2030) ($MN)
7 Global Spatial OMICS Market Outlook, By Software (2022-2030) ($MN)
8 Global Spatial OMICS Market Outlook, By Bioinformatics Tools (2022-2030) ($MN)
9 Global Spatial OMICS Market Outlook, By Imaging Tools (2022-2030) ($MN)
10 Global Spatial OMICS Market Outlook, By Storage & Management Databases (2022-2030) ($MN)
11 Global Spatial OMICS Market Outlook, By Sample Type (2022-2030) ($MN)
12 Global Spatial OMICS Market Outlook, By Formalin-Fixed Paraffin-Embedded (FFPE) Tissue (2022-2030) ($MN)
13 Global Spatial OMICS Market Outlook, By Fresh Frozen Tissue (2022-2030) ($MN)
14 Global Spatial OMICS Market Outlook, By Workflow (2022-2030) ($MN)
15 Global Spatial OMICS Market Outlook, By Sample Preparation (2022-2030) ($MN)
16 Global Spatial OMICS Market Outlook, By Instrumental Analysis (2022-2030) ($MN)
17 Global Spatial OMICS Market Outlook, By Data Analysis (2022-2030) ($MN)
18 Global Spatial OMICS Market Outlook, By Technology (2022-2030) ($MN)
19 Global Spatial OMICS Market Outlook, By Spatial Transcriptomics (2022-2030) ($MN)
20 Global Spatial OMICS Market Outlook, By Spatial Proteomics (2022-2030) ($MN)
21 Global Spatial OMICS Market Outlook, By Spatial Genomics (2022-2030) ($MN)
22 Global Spatial OMICS Market Outlook, By Application (2022-2030) ($MN)
23 Global Spatial OMICS Market Outlook, By Diagnostics (2022-2030) ($MN)
24 Global Spatial OMICS Market Outlook, By Translation Research (2022-2030) ($MN)
25 Global Spatial OMICS Market Outlook, By Drug Discovery and Development (2022-2030) ($MN)
26 Global Spatial OMICS Market Outlook, By Single Cell Analysis (2022-2030) ($MN)
27 Global Spatial OMICS Market Outlook, By Cell Biology (2022-2030) ($MN)
28 Global Spatial OMICS Market Outlook, By Other Applications (2022-2030) ($MN)
29 Global Spatial OMICS Market Outlook, By End User (2022-2030) ($MN)
30 Global Spatial OMICS Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
31 Global Spatial OMICS Market Outlook, By Biopharmaceutical & Biotechnological Companies (2022-2030) ($MN)
32 Global Spatial OMICS Market Outlook, By Contract Research Organization (2022-2030) ($MN)
33 Global Spatial OMICS Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.